Details
Stereochemistry | ACHIRAL |
Molecular Formula | 2O.Th |
Molecular Weight | 264.0369 |
Optical Activity | NONE |
Defined Stereocenters | 0 / 0 |
E/Z Centers | 0 |
Charge | 0 |
SHOW SMILES / InChI
SMILES
[O--].[O--].[Th+4]
InChI
InChIKey=DNNLEMIRRGUGOZ-UHFFFAOYSA-N
InChI=1S/2O.Th/q2*-2;+4
Molecular Formula | Th |
Molecular Weight | 232.0381 |
Charge | 4 |
Count |
|
Stereochemistry | ACHIRAL |
Additional Stereochemistry | No |
Defined Stereocenters | 0 / 0 |
E/Z Centers | 0 |
Optical Activity | NONE |
Molecular Formula | HO |
Molecular Weight | 17.0073 |
Charge | -1 |
Count |
|
Stereochemistry | ACHIRAL |
Additional Stereochemistry | No |
Defined Stereocenters | 0 / 0 |
E/Z Centers | 0 |
Optical Activity | NONE |
Thorium dioxide, a main component of Thorotrast that was used as a contrast agent for cerebral angiography. Thorotrast is an alpha emitter and primary site of deposition is the reticuloendothelial system including the liver, spleen, bone marrow, and lymph nodes. However was discovered, that this compound can cause hepatic angiosarcoma with a long latent period. That is why this contrast agent was withdrawn.
Approval Year
PubMed
Title | Date | PubMed |
---|---|---|
Hepatic angiosarcoma associated with androgenic-anabolic steroids. | 1979 Nov 24 |
|
Alteration of the c-fms gene in a blood sample from a Thorotrast individual. | 1992 Jul |
|
p53 mutations in primary hepatic angiosarcomas not associated with vinyl chloride exposure. | 1995 Nov |
Patents
Substance Class |
Chemical
Created
by
admin
on
Edited
Fri Dec 15 15:38:34 GMT 2023
by
admin
on
Fri Dec 15 15:38:34 GMT 2023
|
Record UNII |
9XA7X17UQC
|
Record Status |
Validated (UNII)
|
Record Version |
|
-
Download
Name | Type | Language | ||
---|---|---|---|---|
|
Official Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English |
Classification Tree | Code System | Code | ||
---|---|---|---|---|
|
NCI_THESAURUS |
C390
Created by
admin on Fri Dec 15 15:38:34 GMT 2023 , Edited by admin on Fri Dec 15 15:38:34 GMT 2023
|
||
|
CFR |
21 CFR 310.502
Created by
admin on Fri Dec 15 15:38:34 GMT 2023 , Edited by admin on Fri Dec 15 15:38:34 GMT 2023
|
Code System | Code | Type | Description | ||
---|---|---|---|---|---|
|
SUB15543MIG
Created by
admin on Fri Dec 15 15:38:34 GMT 2023 , Edited by admin on Fri Dec 15 15:38:34 GMT 2023
|
PRIMARY | |||
|
1314-20-1
Created by
admin on Fri Dec 15 15:38:34 GMT 2023 , Edited by admin on Fri Dec 15 15:38:34 GMT 2023
|
PRIMARY | |||
|
DTXSID0051657
Created by
admin on Fri Dec 15 15:38:34 GMT 2023 , Edited by admin on Fri Dec 15 15:38:34 GMT 2023
|
PRIMARY | |||
|
C1449
Created by
admin on Fri Dec 15 15:38:34 GMT 2023 , Edited by admin on Fri Dec 15 15:38:34 GMT 2023
|
PRIMARY | |||
|
m10801
Created by
admin on Fri Dec 15 15:38:34 GMT 2023 , Edited by admin on Fri Dec 15 15:38:34 GMT 2023
|
PRIMARY | Merck Index | ||
|
215-225-1
Created by
admin on Fri Dec 15 15:38:34 GMT 2023 , Edited by admin on Fri Dec 15 15:38:34 GMT 2023
|
PRIMARY | |||
|
169899
Created by
admin on Fri Dec 15 15:38:34 GMT 2023 , Edited by admin on Fri Dec 15 15:38:34 GMT 2023
|
PRIMARY | |||
|
37339
Created by
admin on Fri Dec 15 15:38:34 GMT 2023 , Edited by admin on Fri Dec 15 15:38:34 GMT 2023
|
PRIMARY | |||
|
100000077000
Created by
admin on Fri Dec 15 15:38:34 GMT 2023 , Edited by admin on Fri Dec 15 15:38:34 GMT 2023
|
PRIMARY | |||
|
THORIUM DIOXIDE
Created by
admin on Fri Dec 15 15:38:34 GMT 2023 , Edited by admin on Fri Dec 15 15:38:34 GMT 2023
|
PRIMARY | |||
|
D013911
Created by
admin on Fri Dec 15 15:38:34 GMT 2023 , Edited by admin on Fri Dec 15 15:38:34 GMT 2023
|
PRIMARY | |||
|
9XA7X17UQC
Created by
admin on Fri Dec 15 15:38:34 GMT 2023 , Edited by admin on Fri Dec 15 15:38:34 GMT 2023
|
PRIMARY | |||
|
6364
Created by
admin on Fri Dec 15 15:38:34 GMT 2023 , Edited by admin on Fri Dec 15 15:38:34 GMT 2023
|
PRIMARY |